CVS Health (NYSE: CVS) reported Q4 EPS of $1.09, $0.09 better than the analyst estimate of $1.00. Revenue for the quarter came in at $105.7 billion versus the consensus estimate of $103.63 billion.

GUIDANCE:

CVS Health sees FY2026 EPS of $7.00-$7.20, versus the consensus of $7.17.

For earnings history and earnings-related data on CVS Health (CVS) click here.